1. Home
  2. KYMR vs NCNO Comparison

KYMR vs NCNO Comparison

Compare KYMR & NCNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KYMR
  • NCNO
  • Stock Information
  • Founded
  • KYMR 2015
  • NCNO 2011
  • Country
  • KYMR United States
  • NCNO United States
  • Employees
  • KYMR N/A
  • NCNO N/A
  • Industry
  • KYMR Medicinal Chemicals and Botanical Products
  • NCNO Computer Software: Prepackaged Software
  • Sector
  • KYMR Health Care
  • NCNO Technology
  • Exchange
  • KYMR Nasdaq
  • NCNO Nasdaq
  • Market Cap
  • KYMR 3.1B
  • NCNO 3.2B
  • IPO Year
  • KYMR 2020
  • NCNO 2020
  • Fundamental
  • Price
  • KYMR $47.28
  • NCNO $30.25
  • Analyst Decision
  • KYMR Strong Buy
  • NCNO Buy
  • Analyst Count
  • KYMR 15
  • NCNO 16
  • Target Price
  • KYMR $58.53
  • NCNO $34.40
  • AVG Volume (30 Days)
  • KYMR 599.5K
  • NCNO 2.4M
  • Earning Date
  • KYMR 10-30-2025
  • NCNO 08-26-2025
  • Dividend Yield
  • KYMR N/A
  • NCNO N/A
  • EPS Growth
  • KYMR N/A
  • NCNO N/A
  • EPS
  • KYMR N/A
  • NCNO N/A
  • Revenue
  • KYMR $44,711,000.00
  • NCNO $573,119,000.00
  • Revenue This Year
  • KYMR $58.45
  • NCNO $9.70
  • Revenue Next Year
  • KYMR N/A
  • NCNO $8.80
  • P/E Ratio
  • KYMR N/A
  • NCNO N/A
  • Revenue Growth
  • KYMR N/A
  • NCNO 13.24
  • 52 Week Low
  • KYMR $19.45
  • NCNO $18.75
  • 52 Week High
  • KYMR $53.27
  • NCNO $43.20
  • Technical
  • Relative Strength Index (RSI)
  • KYMR 64.57
  • NCNO 53.86
  • Support Level
  • KYMR $42.71
  • NCNO $29.61
  • Resistance Level
  • KYMR $44.43
  • NCNO $31.93
  • Average True Range (ATR)
  • KYMR 1.98
  • NCNO 1.20
  • MACD
  • KYMR 0.60
  • NCNO -0.07
  • Stochastic Oscillator
  • KYMR 91.51
  • NCNO 39.44

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.

About NCNO nCino Inc.

Ncino Inc is a provider of cloud-based software for financial institutions. Its software solution digitizes, automates, and streamlines inefficient and complex processes & workflows and utilizes data analytics & artificial intelligence that enables financial institutions to onboard new clients, make loans, and manage the entire loan life cycle, open deposits, and other accounts, and manage regulatory compliance. It also offers professional services, including configuration & implementation, training, and advisory services. The company generates the majority of its revenue from subscription services. The company caters to financial institutions, enterprise banks, regional banks, community banks, and credit unions. The vast majority of its revenue comes from the United States.

Share on Social Networks: